The CAR-T Experience: Lessons Learned In The Quest For Speed And Performance

By: Sankalp Sethi, Shabnam Mehta, Tim Frost and Madeleine Hicks

More than 12,000 patients globally have benefited from CAR-T cell therapies in the five years that they have been commercially available. While the clinical benefits have transformed patients’ lives, the overall customer experience with CAR-Ts leaves room for improvement. The burden on providers is starting to mount, and many say there is a limit to the number of cell therapies they can handle. Our team set out to understand current provider experiences with CAR-T. The journey to deliver these individualized therapies to the appropriate patients on time can be as painstaking as building a championship Formula 1 car. Read more to learn about the numerous opportunities to create differentiation and establish long-term leadership that our research uncovered and how CAR-T manufacturers can refine the processes and experience in clinical trials.